Lately, a study has proven that the protein, which decrease the risk of cancer is not as much active in man as in womanhood. This work is published in The Journal of Clinical Investigationand proved after several experiments performed on a cell model glioblastoma. In this experiment they expose both male and female brain cells to numerous gene variations. The outcome of this experiment comes out that the tumors develop more quickly and frequently in male brain cells as compared to the female cells.
For the verification of this experiment, researchers examine three genes neurofibromin, p53 and RB. These genes usually reduce the growth of tumor through curbing cell division. The examiners observed that in many cancer patients these genes were out of action or mutated.
According to senior author Joshua Rubin, later on these outcomes, doctors should begin the research on tumor again since no one has ever connected the sex factor in tumor. They normally analyze and treat both man and woman in a same way and this study will make them evaluate the reports of male and female differently. After this research several other questions arise in the minds of doctors for instance, whether there should be different treatments for man and woman who suffer from a tumor.
Previously scientist has discovered a number of diseases which have higher rates in man and lower rates in woman. Mostly these diseases are associated with hormonal changes.